MONOCYTE CHEMOATTRACTANT PROTEIN-1 (MCP-1) EXPRESSION IN HUMAN ARTICULAR-CARTILAGE - INDUCTION BY PEPTIDE REGULATORY FACTORS AND DIFFERENTIAL-EFFECTS OF DEXAMETHASONE AND RETINOIC ACID

被引:132
作者
VILLIGER, PM
TERKELTAUB, R
LOTZ, M
机构
[1] UNIV CALIF SAN DIEGO,DEPT MED,9500 GILMAN DR,LA JOLLA,CA 92093
[2] UNIV CALIF SAN DIEGO,SAM & ROSE STEIN INST RES AGING,LA JOLLA,CA 92093
[3] SAN DIEGO VET AFFAIRS MED CTR,LA JOLLA,CA 92093
关键词
CHONDROCYTES; CARTILAGE; MONOCYTE CHEMOATTRACTANT PROTEIN-1; LEUKEMIA INHIBITORY FACTOR; TRANSFORMING GROWTH FACTOR-BETA; RETINOIC ACID;
D O I
10.1172/JCI115885
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Monocyte influx and activation in synovial joints are important in the pathogenesis of both degenerative and inflammatory arthropathies. In this study, we demonstrate the potential of articular cartilage to directly modulate these events. IL-1-stimulated human articular chondrocytes transcribed 0.7-kb monocyte chemoattractant protein-1 (MCP-1) mRNA. In situ hybridization of cartilage organ cultures revealed MCP-1 transcripts in chondrocytes in the superficial tangential zone within 2 h of stimulation with IL-1. Chondrocytes in deeper layers responded by 4 h and reached maximum MCP-1 mRNA levels by 8-12 h. IL-1-stimulated cartilage organ and chondrocyte monolayer cultures released functional monocyte chemotactic activity. This was neutralized by a monoclonal antibody specific for MCP-1, and was associated with the synthesis and secretion of immunoreactive 13-kD and 15-kD isoforms of MCP-1. Regulators and signal transduction pathways involved with the expression of the MCP-1 gene in chondrocytes were analyzed. Steady-state mRNA levels were increased by the known chondrocyte activators IL-1, tumor necrosis factor alpha, LPS, platelet-derived growth factor, and transforming growth factor beta. In addition, leukemia inhibitory factor induced MCP-1 gene expression and protein synthesis, identifying this cytokine as a new regulator of chondrocyte function. Dexamethasone blunted the induction of MCP-1 gene expression by IL-1 and by activators of protein kinase A as well as protein kinase C signal transduction pathways. In contrast, retinoic acid strongly increased phorbol myristate acetate-induced MCP-1 expression and potentiated the effects of IL-1 and LPS. In conclusion, chondrocytes express MCP-1 in response to factors that are present in cartilage or synovium. This provides a mechanism by which cartilage can play an active role in the initiation and progression of arthritis.
引用
收藏
页码:488 / 496
页数:9
相关论文
共 47 条
  • [1] RAPID ONSET SYNOVIAL INFLAMMATION AND HYPERPLASIA INDUCED BY TRANSFORMING GROWTH FACTOR-BETA
    ALLEN, JB
    MANTHEY, CL
    HAND, AR
    OHURA, K
    ELLINGSWORTH, L
    WAHL, SM
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 171 (01) : 231 - 247
  • [2] BRANDES ME, 1991, J IMMUNOL, V147, P1600
  • [3] TRANSFORMING GROWTH FACTOR-BETA IS A POTENT INHIBITOR OF IL-1 INDUCED PROTEASE ACTIVITY AND CARTILAGE PROTEOGLYCAN DEGRADATION
    CHANDRASEKHAR, S
    HARVEY, AK
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1988, 157 (03) : 1352 - 1359
  • [4] CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
  • [5] A 48-WELL MICRO CHEMOTAXIS ASSEMBLY FOR RAPID AND ACCURATE MEASUREMENT OF LEUKOCYTE MIGRATION
    FALK, W
    GOODWIN, RH
    LEONARD, EJ
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1980, 33 (03) : 239 - 247
  • [6] ACTIVE AND LATENT FORMS OF TRANSFORMING GROWTH FACTOR-BETA ACTIVITY IN SYNOVIAL EFFUSIONS
    FAVA, R
    OLSEN, N
    KESKIOJA, J
    MOSES, H
    PINCUS, T
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 169 (01) : 291 - 296
  • [7] CLONING AND SEQUENCING OF THE CDNA FOR HUMAN MONOCYTE CHEMOTACTIC AND ACTIVATING FACTOR (MCAF)
    FURUTANI, Y
    NOMURA, H
    NOTAKE, M
    OYAMADA, Y
    FUKUI, T
    YAMADA, M
    LARSEN, CG
    OPPENHEIM, JJ
    MATSUSHIMA, K
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 159 (01) : 249 - 255
  • [8] GIGUERE V, 1989, NATURE, V337, P556
  • [9] GROSS V, 1991, Arthritis and Rheumatism, V34, pS144
  • [10] GUERNE PA, 1990, J IMMUNOL, V144, P499